Treatment with mesenchymal stem cells improves liver regeneration in early-stage cirrhosis
Mesenchymal stem cell (MSC) therapy shows promise in enhancing liver regeneration during early-stage cirrhosis. This analytical review explores the efficacy and mechanisms of MSC treatment, examining its potential to improve clinical outcomes and offering insights for future therapeutic strategies. {İÇERİK}